Literature DB >> 17219421

Protein kinase C delta enhances proliferation and survival of murine mammary cells.

Valeria C Grossoni1, Karina B Falbo, Marcelo G Kazanietz, Elisa D Bal de Kier Joffé, Alejandro J Urtreger.   

Abstract

Protein kinase C (PKC) delta, a member of the novel family of PKC serine-threonine kinases, has been implicated in negative regulation of proliferation and apoptosis in a large number of cell types, including breast cancer cell lines, and postulated as a tumor suppressor gene. In this study we show that in murine NMuMG mammary cells PKCdelta promotes a mitogenic response. Overexpression of PKCdelta in NMuMG cells leads to a significant increase in [3H]-tymidine incorporation and cell proliferation, as well as enhanced extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK) activation. Activation of PKCdelta with a phorbol ester leads to elevated cyclin D1 expression and an hyperphosphorylated Rb state. Surprisingly, ectopic expression of PKCdelta conferred anchorage-independent growth capacity to NMuMG cells. PKCdelta overexpressors showed enhanced resistance to apoptotic stimuli, such as serum deprivation or doxorubicin treatment, an effect that correlates with hyperactivation of the Akt survival pathway. Our results provide evidence for a role of PKCdelta as a positive modulator of proliferative and survival signals in immortalized mammary cells. The fact that PKCdelta exerts differential responses depending on the cell context not only highlights the necessity to carefully understand the signaling events controlled by this PKC in each cell type but also suggests that we should be cautious in considering this kinase a target for cancer therapy. Copyright (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17219421     DOI: 10.1002/mc.20287

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  20 in total

1.  Inhibition of PKCδ reduces cisplatin-induced nephrotoxicity without blocking chemotherapeutic efficacy in mouse models of cancer.

Authors:  Navjotsingh Pabla; Guie Dong; Man Jiang; Shuang Huang; M Vijay Kumar; Robert O Messing; Zheng Dong
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Transformer 2β homolog (Drosophila) (TRA2B) regulates protein kinase C δI (PKCδI) splice variant expression during 3T3L1 preadipocyte cell cycle.

Authors:  Rekha S Patel; Gay Carter; Denise R Cooper; Hercules Apostolatos; Niketa A Patel
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

3.  Protein kinase Cα suppresses the expression of STC1 in MDA-MB-231 breast cancer cells.

Authors:  Louise Cornmark; Gry Kalstad Lønne; Annika Jögi; Christer Larsson
Journal:  Tumour Biol       Date:  2011-07-01

4.  PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells.

Authors:  Hanying Zhang; Miyako Okamoto; Evgeniy Panzhinskiy; W Michael Zawada; Mita Das
Journal:  Am J Physiol Cell Physiol       Date:  2014-02-05       Impact factor: 4.249

Review 5.  Protein kinase C and cancer: what we know and what we do not.

Authors:  R Garg; L G Benedetti; M B Abera; H Wang; M Abba; M G Kazanietz
Journal:  Oncogene       Date:  2013-12-16       Impact factor: 9.867

6.  Protein kinase Cdelta supports survival of MDA-MB-231 breast cancer cells by suppressing the ERK1/2 pathway.

Authors:  Gry Kalstad Lønne; Katarzyna Chmielarska Masoumi; Johan Lennartsson; Christer Larsson
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

7.  PKCalpha expression is a marker for breast cancer aggressiveness.

Authors:  Gry Kalstad Lønne; Louise Cornmark; Iris Omanovic Zahirovic; Göran Landberg; Karin Jirström; Christer Larsson
Journal:  Mol Cancer       Date:  2010-04-14       Impact factor: 27.401

8.  ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.

Authors:  Jing-Shan Tong; Qing-Hua Zhang; Zhen-Bo Wang; Sen Li; Cai-Rong Yang; Xue-Qi Fu; Yi Hou; Zhao-Yi Wang; Jun Sheng; Qing-Yuan Sun
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

9.  Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.

Authors:  B L Allen-Petersen; C J Carter; A M Ohm; M E Reyland
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

Review 10.  Role of ER-α36 in breast cancer by typical xenoestrogens.

Authors:  Jun Liu; Zhixiang Xu; Xiaodong Ma; Bin Huang; Xuejun Pan
Journal:  Tumour Biol       Date:  2015-09-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.